Neurogenomics Conference
Categoria: Seminario / Conferenza
Luogo: Human Technopole - In presenza
Iscrizioni entro: Registrations will open in Dec 2024
Data: 19/05/2025 - 21/05/2025
Target: Researchers, early-career scientists, postdoctoral fellows, and graduate students who wish to share and advance knowledge in neuropsychiatric and neurological diseases.
This groundbreaking conference aims to engage the leading communities from the main fields of research our institute is pursuing in Neurogenomics, focusing on the neurodiverse human condition and its neurodevelopmental and neurodegenerative vulnerabilities . By leveraging the interdisciplinarity of HT Neurogenomics themes, the goal is to foster international synergies across diverse academic communities through a vibrant mix of keynote lectures, talks and discussions to celebrate the diversity and integrative challenges of human neuroscience. Whether you are an accomplished group leader or an emerging talent, whether neuroscience is already your home, or you are considering moving in, look no further to keep abreast and engage with the latest developments.
Selection
Registration will be on a first come, first served basis.
Applicants are encouraged to submit an abstract for oral or poster presentation which will be selected based on the following criteria:
- Scientific content of abstract
- Scientific relevance of the conference to participant’s own work
- Number of participants from the same lab
Abstracts can be submitted for one or more of the conference topics:
- Neurodevelopment
- Brain evolution
- Neurodegeneration and regeneration
- Neuroimmunology
- Stem cell and organoid disease modelling
- Cancer neuroscience
Image credits: Chiara Ossola (Kalebic group, Human Technopole). Ferret hippocampus at postnatal day 10. Markers: Green, Hopx; Magenta, Sox2; Yellow, PH3, Cyan, DAPI.
Write to training@fht.org if you are interested in attending the conference. We will e-mail you to the same address once registrations are open.
Scientific Organisers
-
Jose Davila-Velderrain
Research Group Leader, HT -
Oliver Harschnitz
Research Group Leader, HT -
Nereo Kalebic
Research Group Leader, HT -
Elena Taverna
Research Group Leader, HT -
Giuseppe Testa
Head of Neurogenomics, HT
Speakers
-
Ido Amit
Weizmann Institute of Science -
Elisabeth Binder
Max Planck Institute of Psychiatry -
Cedric Boeckx
Catalan Institute for Advanced Studies (ICREA), Universitat de Barcelona -
Boyan Bonev
Helmholtz Pioneer Campus -
Thomas Bourgeron
Institut Pasteur, Université de Paris -
Silvia Cappello
Ludwig Maximilian University of Munich – LMU -
Goncalo Castelo-Branco
Karolinska Institutet -
Matthew Cobb
The University of Manchester -
Sally Cowley
University of Oxford -
Bart De Strooper
VIB-KU Leuven Center for Brain & Disease Research -
Aleksandra Deczkowska
Institut Pasteur -
Daniel Geschwind
UCLA -
Florent Ginhoux
Agency for Science, Technology and Research (A*STAR) -
Yukiko Gotoh
University of Tokyo -
Bassem Hassan
Institut du Cerveau -
Wieland Huttner
Max Planck Institute of Molecular Cell Biology and Genetics -
Leah Krubitzer
University of California, Davis -
Simona Lodato
Humanitas Research Centre -
Claire Magnon
Laboratory of Cancer and Microenvironment-National Institute of Health and Medical Research (INSERM), Institute of Biology François Jacob-Atomic Energy Commission (CEA), University of Paris Cité, University of Paris-Saclay, -
Oscar Marin
Kings College London -
Guo-li Ming
Perelman School of Medicine, University of Pennsylvania -
Tom Nowakowski
University of California San Francisco -
Sergiu Pasca
Stanford University -
Armin Raznahan
Section on Developmental Neurogenomics, National Institute of Mental Health -
Hongjun Song
Perelman School of Medicine, University of Pennsylvania -
Elly Tanaka
Research Institute of Molecular Pathology (IMP) -
Roberto Toro
Institut Pasteur -
Pierre Vanderhaeghen
VIB Center for Brain and Disease Research, Leuven Brain Institute, KULeuven -
Varun Venkataramani
German Cancer Research Center (DKFZ), University Hospital Heidelberg